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ABSTRACT 
 
This study evaluated effects of an aqueous extract of Ganoderma lucidum (reishi) on the labeling of blood 
constituents with technetium-99m (99mTc) and on the survival of cultures of Escherichia coli treated with stannous 
chloride. Blood samples from Wistar rats were treated with reishi extract, radiolabeling procedure was performed, 
plasma (P), blood cells (BC) and insoluble (IF) and soluble (SF) fractions of P and BC were separated. The 
radioactivity was counted for the determination of the percentages of radioactivity (%ATI). Cultures of Escherichia 
coli AB1157 were treated with stannous chloride in the presence and absence of reishi extract. Blood samples and 
bacterial cultures treated with NaCl 0.9% were used as controls. Data indicated that reishi extract altered 
significantly (p<0.05) the %ATI of P, BC, IF-P, SF-P, IF-BC and SF-BC, as well as increased the survival of 
bacterial cultures treated with stannous chloride. Our results suggest that reishi extract could present a 
redox/chelating action, altering the labeling of blood constituents with 99mTc and protecting bacterial cultures 
against oxidative damage induced by stannous chloride.  
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INTRODUCTION 
 
Ganoderma lucidum (reishi) is a traditional 
chinese medicine product known to the layman as 
the “herb of immortality”. It has been used as a 
health tonic to promote longevity for more than 
two thousand years. Reishi extract contains two 
major groups of bioactive polysaccharide and 
triterpene components (Bao et al., 2002). These 
compounds in reishi have been studied due to their 
potential immunomodulating activity and anti-
tumor effect, as demonstrated in both in vitro and 
in vivo models (Lin et al., 2004). 
Pharmacological effects and physiological 
properties of reishi include immune enhancement, 
maintenance of homeostasis and regulation of 
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biorhythm, and prevention of and improvement 
against some diseases, including cancer, cerebral 
stroke and heart disease (Lin et al., 2004). Other 
authors have suggested antifungal, anti-
inflammatory, antitumor, antiviral, antibacterial, 
hepatoprotective, antidiabetic, hypolipedemic, 
antithrombotic and hypotensive activities for reishi 
(Ajith et al., 2007). 
Red blood cells labeled with technetium-99m 
(99mTc-RBC) are used in clinical nuclear medicine 
for diagnostic evaluations (Verdu et al., 2005; 
Olds et al., 2005). Thus, the labeling of RBC with 
99mTc has been also used as an assay to investigate 
the properties of different chemical agents 
(Fonseca et al., 2007). This radiolabeling depends 
on the presence of a reducing agent and stannous 
chloride has being widely utilized (Saha, 2004). 
Although, the stannous ion has clinical utilization, 
some authors have suggested that stannous 
chloride appears to induce lesions in the 
deoxyribonucleic acid (DNA) by oxidative 
mechanisms related to free radical generation (El-
Demerdash et al., 2005; Presta et al., 2007), which 
could result in cell inactivation or potentially 
tumorigenesis and protection against this effect 
would be of particular interest in nuclear medicine, 
where stannous chloride is used for the preparation 
of radiopharmaceuticals (Saha, 2004).  
Thus, the aim of this work study was to verify the 
effects of an extract of reishi on the labeling of 
blood constituents with 99mTc and on the survival 
of Escherichia coli cultures treated with stannous 
chloride. 
 
 
MATERIALS AND METHODS 
 
Extract preparation 
Ganoderma lucidum (GL) (0,35 g) (SKL Herbal 
Científica Laboratório Farmacêutico Ltda., lot 
number 201221, validity November 2008). The 
extract of reishi was prepared with 0.35 g of a 
purified powder in 100 mL of 0.9% NaCl (saline). 
The preparation was homogenized in a vortex 
mixer and centrifuged (2000 rpm, 10 minutes). 
The supernatant was collected and considered to 
be 3.5 mg/mL.  
 
Spectrophotometric measurements 
Spectrophotometric analysis (TV-VIS 
Spectrophotometer Beijing Purkinje General 
Instrument Co., Ltd, Beijing, People’s Republic of 
China) of the extract at 3.5 mg/ml was carried out. 
An absorption peak (0.56±0.01) was obtained at 
255 nm and it was used as a marker of 
reproducibility preparation of this extract.  
 
Animals  
Wistar rats (n= 12, 3-4 months, 245±35g) were 
kept under controlled environmental conditions 
(25±2oC, 12h of light/dark cycle), water and 
libitum and normal diet. Heparinized whole blood 
was withdrawn by cardiac puncture from animals 
under anesthesia by sodium thiopental (40mg/kg). 
All the experimental procedures followed the 
Ethical Guidelines of the Instituto de Biologia 
Roberto Alcantra Gomes, Universidade do Estado 
do Rio de Janeiro with the protocol number CEA/ 
115/2006. 
 
Labeling of blood constituents with 99mTc 
Blood samples (n = 8, for each extract 
concentration) of whole blood were incubated with 
reishi extract (0.0, 0.2, 0.4, 0.85, 1.75 and 
3.5mg/mL, 1 hour). After that, a freshly prepared 
stannous chloride solution (SnCl2, 1.2µg/ml, 
Sigma Chemical Co. St Louis, USA, 1 hour) was 
added. Then, 99mTc (3.7 MBq, 10 minutes) was 
added. These samples were centrifuged (1500 rpm, 
5 minutes) and plasma (P) and blood cells (BC) 
were separated. Aliquots of P and BC were also 
precipitated in trichloroacetic acid (5%) and 
soluble (SF) and insoluble (IF) fractions were 
obtained. Radioactivity (%ATI) in P, BC, IF-P, 
SF-P, IF-BC and SF-BC was determined in a well 
gamma counter (Clinigamma, gamma counter, 
Packard, Instrument Company, mod C5002, USA). 
The percentage of incorporated radioactivity 
(%ATI) was calculated as previously described 
(Bernardo Filho et al., 1983). The data were 
expressed as mean ± standard deviation of %ATI. 
The values were analyzed by one-way variance 
analysis (ANOVA) with a p<0.05 as significant 
level followed by Bonferroni post-test.  
 
Bacterial inactivation 
E. coli AB1157, a wild-type strain, proficient in 
repairing DNA damage, was used in this work. 
From stock (in glycerol 50% v/v), an aliquot was 
grown in liquid LB (Luria and Burrous, 1957) 
medium at 37 °C overnight up to stationary growth 
phase. An aliquot was taken from this culture and 
further incubated under the same conditions to 
reach exponential growth (108 cells/mL). The cells 
were collected by centrifugation, washed twice in 
saline and suspended again in saline. After that, 
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bacterial suspensions (108 cells/mL) were treated 
with stannous chloride (25 µg/mL) in the presence 
or absence of reishi extract (1.75 and 3.5 mg/mL) 
for 60 minutes. Aliquots from these treatments 
were diluted in saline, spread onto Petri dishes 
containing solidified LB medium (1.5% agar). 
Colonies formed after overnight incubation at 37 
oC were counted and the survival fraction was 
calculated as described before (Almeida et al., 
2007). Experiments were carried out in triplicate 
and the results presented are the average mean of 
three independent assays. 
RESULTS  
 
Table 1 presents the %ATI of the plasma and 
blood cells from blood samples treated with reishi 
extract. These data suggest that reishi extract at the 
highest concentrations used (1.75 and 3.5 mg/mL) 
alters the distribution of radioactivity between 
plasma and cellular components.  
 
 
 
Table 1 - Effect of the treatment with reishi extract on the distribution of radioactivity between plasma and cellular 
compartments. 
Ganoderma 
(mg/mL) % ATI                          
 P BC 
0.0 7.18±0.93 92.82±0.93 
0.2 6.17±5.33 93.83±5.33 
0.4 2.56±1.39 97.44±1.49 
0.85 2.91±0.86 97.09±0.86 
1.75 41.75±3.76 * 58.25±3.76 * 
3.5 54.89±1.82 * 45.11±1.82 * 
(*) p<0.05 when compared with control. 
 
 
Table 2 presents the %ATI of the insoluble and 
soluble fractions of plasma. Data suggest that 
reishi extract treatment at highest concentrations 
(0.85, 1.75 and 3.5 mg/mL) also alters the fixation 
of radioactivity on plasma proteins. 
 
 
Table 2 - Effect of reishi extract on the fixation of radiactivity on plasma fractions. 
Ganoderma 
(mg/mL) % ATI  
 IF-P SF-P 
0.0 67.89±4.35 32.11±4.35 
0.2 64.52±4.04 35.48±4.04 
0.4 68.68±3.85 31.32±3.85 
0.85 53.85±2.20 * 46.15±2.20 * 
1.75 14.15±8.60 * 85.85±8.60 * 
3.5 6.30±0.48 * 93.70±0.48 * 
Insoluble fraction of the plasma (IF-P), soluble fraction of the plasma (SF-P). (*) p<0.05 when compared with control. 
 
 
Table 3 presents the %ATI of the insoluble and 
soluble fractions of blood cells. Data suggest that 
reishi extract treatment at the higher concentration 
(3.5 mg/mL) alters the fixation of radioactivity on 
cellular proteins. 
Figure 1 shows the survival fractions of E. coli 
AB1157 cultures treated with SnCl2 in the 
presence and absence of reishi extract, 
demonstrating that reishi offers protection from 
free radicals generated by stannous chloride. 
Data in figure 1 suggest that the treatment with 
reishi extract would not present cytotoxic effects 
on E. coli AB1157 cell cultures, in the absence of 
stannous chloride, but would increase the survival 
of these cultures treated with stannous chloride, 
particularly at the higher dose. 
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Table 3 - Effect of reishi extract on the fixation of radiactivity on blood cell fractions. 
Ganoderma 
(mg/mL) % ATI  
 
IF-BC SF-BC 
0.0 89.85±2.81 10.15±2.81 
0.2 89.27±7.74 10.73±7.74 
0.4 93.03±1.73 6.97±1.73 
0.85 89.97±4.34 10.03±4.34 
1.75 74.19±10.40 25.81±10.40 
3.5 26.30±0.53 * 73.70±0.53 * 
Insoluble fraction of the blood cells (IF-BC), soluble fractions of the blood cells (SF-BC). (*) p<0.05 when compared with 
control. 
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Figure 1 - Survival fractions of E. coli AB1157 cultures treated with stannous chloride in the 
presence and absence of reishi extract. E. coli AB 1157 cultures were treated with 
stannous chloride (SnCl2, 25 µg/mL) in presence and absence of reishi extract (17.5 
and 35 mg/mL), aliquots were diluted in saline and spread onto Petri dishes. After 
overnight incubation (37 oC), colony forming units were counted to determine 
survival fractions. (♦) control; (■) SnCl2; (□) SnCl2+1.75mg/mL reishi; (●) 
SnCl2+3.5mg/mL reishi; (×) reishi extract 1.75mg/mL; (▲) reishi extract 3.5mg/mL. 
 
 
 
DISCUSSION 
 
There is evidence that natural drugs could affect 
the radiolabeling of blood constituents, and these 
findings have been considered in the development 
of this procedure as an experimental model to 
verify the properties of these drugs (Benarroz et 
al., 2008; Frydman et al., 2008). 
The analysis of tables 1, 2 and 3 indicates that 
there was an important alteration on the 
radiolabeling of the blood constituents from blood 
samples treated with reishi extract. It is interesting 
to note that although in the absence of reishi nearly 
93% of ATI was in the cellular component, this 
shifted to almost equal distribution between on 
plasma and blood cells compartments at high 
reishi concentrations. Furthermore, there was a 
shift in the labeling of soluble and insoluble 
fractions, where the %ATI in the insoluble 
fractions changed from nearly 70% to less than 
7%, with a corresponding increase of labeling in 
the soluble fractions. The pattern was similar in 
the labeling of the cellular component, with a shift 
of the highest labeling (expressed as %ATI) from 
the insoluble towards the soluble fractions. 
Previous studies have demonstrated that reishi 
extracts act on humoral immune response (Bao et 
al., 2002; Lin et al., 2005) and a polysaccharide 
isolated from reishi has been shown to increase the 
response to sheep RBC in mice (Lin et al., 2004). 
In vitro, reishi polysaccharides also increased 
lymphocyte proliferation (Cao et al., 2003). 
Radiolabeling data obtained in this study could be 
related to actions of reishi polysaccharides on 
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blood constituents. Another possibility is the 
redox/chelating action of the substances in reishi 
extract. In fact, some natural products could alter 
the labeling of blood constituents with 99mTc by 
interfering on the reducing action of the SnCl2 
(Benarroz et al., 2008). 
To verify this hypothesis, effects of reishi extract 
on E. coli AB1157 treated with SnCl2 were 
evaluated (Figure 1). Our data suggest that the 
extract used could protect E. coli cells against the 
oxidative effect of SnCl2 and indicate that 
chemical compounds in reishi extract present 
redox/chelating activity. In addition, data obtained 
with bacterial cultures treated with reishi in the 
absence of stannous chloride indicate an absence 
of antibacterial action of the reishi extract used. 
Similar findings were obtained with an extract of 
cauliflower (Lima et al., 2002). 
In conclusion, results obtained in this work 
suggest that reishi extract has redox/chelating 
properties, altering the labeling of blood 
constituents with 99mTc and protecting bacterial 
cultures against oxidative damage induced by 
stannous chloride.  
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RESUMO 
 
Este estudo avaliou efeitos de um extrato de 
Ganoderma lucidum (reishi) na marcação de 
constituintes sangüíneos com tecnécio-99m 
(99mTc) e na sobrevivência de culturas de 
Escherichia coli tratadas com cloreto estanoso. 
Amostras de sangue de ratos Wistar foram tratadas 
com extrato de reishi, o procedimento de 
radiomarcação foi realizado, plasma (P), células 
sangüíneas (CS) e frações insolúvel (FI) e solúvel 
(FS) de P e CS foram separadas e a radioatividade 
foi contada para determinação das porcentagens de 
radioatividade (%ATI). Culturas de Escherichia 
coli AB1157 foram tratadas com cloreto estanoso 
na presença e ausência do extrato de reishi. 
Amostras de sangue e culturas bacterianas tratadas 
com NaCl 0.9% foram usadas como controles. 
Dados indicaram que o extrato de reishi alterou 
significativamente (p<0,05) a %ATI de P, CS, FI-
P, FS-P, FI-CS e FS-CS, bem como, aumentou a 
sobrevivência de culturas bacterianas tratadas com 
cloreto estanoso. Nossos resultados sugerem que o 
extrato de reishi poderia apresentar ação 
redox/quelante alterando a marcação de 
constituintes sangüíneos com 99mTc e protegendo 
culturas bacterianas contra lesões oxidativas 
induzidas pelo cloreto estanoso. 
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